Venus Medtech Hangzhou Inc
HKEX:2500
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Venus Medtech Hangzhou Inc
Other Operating Expenses
Venus Medtech Hangzhou Inc
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Venus Medtech Hangzhou Inc
HKEX:2500
|
Other Operating Expenses
-¥38.7m
|
CAGR 3-Years
58%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Other Operating Expenses
¥38.8m
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Other Operating Expenses
¥217m
|
CAGR 3-Years
398%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Other Operating Expenses
¥455.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Other Operating Expenses
-¥54.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
-39%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Other Operating Expenses
¥440.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Venus Medtech Hangzhou Inc
Glance View
Venus Medtech (Hangzhou), Inc. provides transcatheter heart valve medical device. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2019-12-10. The firm's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.
See Also
What is Venus Medtech Hangzhou Inc's Other Operating Expenses?
Other Operating Expenses
-38.7m
CNY
Based on the financial report for Dec 31, 2025, Venus Medtech Hangzhou Inc's Other Operating Expenses amounts to -38.7m CNY.
What is Venus Medtech Hangzhou Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
14%
Over the last year, the Other Operating Expenses growth was 89%. The average annual Other Operating Expenses growth rates for Venus Medtech Hangzhou Inc have been 58% over the past three years , 14% over the past five years .
